NASDAQ:CRON - CA22717L1013 - Common Stock
The current stock price of CRON is 2.48 USD. In the past month the price increased by 7.83%. In the past year, price increased by 13.76%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 44.58 | 681.47B | ||
JNJ | JOHNSON & JOHNSON | 17.84 | 429.61B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.24 | 251.05B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.55 | 249.29B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 14.01 | 243.39B | ||
MRK | MERCK & CO. INC. | 10.88 | 209.29B | ||
PFE | PFIZER INC | 7.24 | 139.49B | ||
SNY | SANOFI-ADR | 10.46 | 113.23B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.88 | 94.20B | ||
GSK | GSK PLC-SPON ADR | 8.82 | 80.27B | ||
ZTS | ZOETIS INC | 24.48 | 67.49B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 52 | 47.63B |
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
CRONOS GROUP INC
4491 Concession Rd 12
TORONTO ONTARIO M5V 2H1 CA
CEO: Kurt Schmidt
Employees: 459
Phone: 14165040004
The current stock price of CRON is 2.48 USD. The price decreased by -0.8% in the last trading session.
The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Nasdaq exchange.
CRON stock is listed on the Nasdaq exchange.
7 analysts have analysed CRON and the average price target is 1.77 USD. This implies a price decrease of -28.72% is expected in the next year compared to the current price of 2.48. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CRONOS GROUP INC (CRON) has a market capitalization of 949.94M USD. This makes CRON a Small Cap stock.
CRONOS GROUP INC (CRON) currently has 459 employees.
CRONOS GROUP INC (CRON) has a support level at 2.47 and a resistance level at 2.59. Check the full technical report for a detailed analysis of CRON support and resistance levels.
The Revenue of CRONOS GROUP INC (CRON) is expected to grow by 12.95% in the next year. Check the estimates tab for more information on the CRON EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CRON does not pay a dividend.
CRONOS GROUP INC (CRON) will report earnings on 2025-11-10.
The PE ratio for CRONOS GROUP INC (CRON) is 49.6. This is based on the reported non-GAAP earnings per share of 0.05 and the current share price of 2.48 USD. Check the full fundamental report for a full analysis of the valuation metrics for CRON.
The outstanding short interest for CRONOS GROUP INC (CRON) is 1.4% of its float. Check the ownership tab for more information on the CRON short interest.
ChartMill assigns a technical rating of 9 / 10 to CRON. When comparing the yearly performance of all stocks, CRON is one of the better performing stocks in the market, outperforming 80.54% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CRON. CRON has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months CRON reported a non-GAAP Earnings per Share(EPS) of 0.05. The EPS increased by 162.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.19% | ||
ROA | 1.57% | ||
ROE | 1.71% | ||
Debt/Equity | 0 |
7 analysts have analysed CRON and the average price target is 1.77 USD. This implies a price decrease of -28.72% is expected in the next year compared to the current price of 2.48.
For the next year, analysts expect an EPS growth of -115.3% and a revenue growth 12.95% for CRON